Diazoxide

DiazoxideCAS号: 364-98-7分子式: C8H7ClN2O2S分子量: 230.67描述纯度储存/保存方法别名外观可溶性/溶解性靶点In vitro(体外研究)In vivo(体内研究)参考文献

产品描述
描述

Diazoxide is a potassium channel activator, which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions.

纯度
>98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
二氮嗪;Sch-6783;SRG-95213
外观
白色或类白色结晶性粉末
可溶性/溶解性
DMSO :43 mg/mL (186.4 mM)
生物活性
靶点
KATP channels
In vitro(体外研究)
Diazoxide inhibits microglial inflammatory activity. Diazoxide treatment partially inhibits the inflammatory pattern induced by LPS/IFN-γ in microglial cells, inducing a decrease in NO production that could be because of the decreased expression of iNOS detected. Diazoxide has no effect on microglial phagocytosis.
In vivo(体内研究)
Diazoxide is beneficial on the improvement in cognitive tasks, reduction of anxiety, decrease in the accumulation of amyloid-beta oligomers and hyperphosphorylation of tau proteins. Diazoxide may also exerts neuroprotective effects independently of K+ channel activation by decreasing neuronal excitability and activation of N-methyl-D-aspartate (NMDA) receptors or by increasing currents troughα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Diazoxide-treated animals show a decrease in disease severity a few days after the first clinical signs are observed, corresponding to the acute inflammatory phase of the disease. Daily oral administration of diazoxide in EAE mice during the effector phase of the disease reduces the severity of the clinical signs without any apparent adverse effect. Diazoxide decreases demyelination and axonal loss, reduces tissue damage, inhibits microglial/macrophage and astrocytic activationand preserves neuron integrity. No effects are observed on the number of B and T lymphocytes infiltrating the spinal cord.
参考文献
参考文献
  • 1. D’hahan N, et al. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12162-7.
  • 2. Lawrence CL,et al. Br J Pharmacol. 2002 Jul; 136(5):746-52.
  • 3. Munoz A, et al. Stroke. 2003 Jan;34(1):164-70.
  • 4. Sakura H, et al. J Physiol. 1999 Dec 1;521 Pt 2:337-50.
  • 5. Guo W, et al. Conf Proc IEEE Eng Med Biol Soc. 2005;4:4027-30.
  • 分子结构图

    Diazoxide